Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Monte Rosa Therapeutics (NASDAQ:GLUE) reported its Q4 earnings results on Thursday, March 14, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Monte Rosa Therapeutics missed estimated earnings by -76.0%, reporting an EPS of $-0.58 versus an estimate of $-0.33.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.02 which was followed by a 3.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Monte Rosa Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: GLUE